Volume 10, Issue 3 (11-1996)                   Med J Islam Repub Iran 1996 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BATYRALIEV T A, AYKlMBAEV K S, KUDEYBERDIEVA G Z, AKGUL F, SODANBEKOVA G K. THE EFFECTS OF CAPTOPRIL ON PULMONARY AND SYS TEMIC ARTERIAL PRESSURES IN HIGHALTITUDE PULMONARY HYPERTENSION. Med J Islam Repub Iran 1996; 10 (3) :179-181
URL: http://mjiri.iums.ac.ir/article-1-1167-en.html
THE EFFECTS OF CAPTOPRIL ON PULMONARY AND SYS TEMIC ARTERIAL PRESSURES IN HIGHALTITUDE PULMONARY HYPERTENSION
TALANTBEK A BATYRALIEV , KAIRGELDY S. AYKlMBAEV , GULMIRA Z. KUDEYBERDIEVA , FERIT AKGUL , GYLDYZ K. SODANBEKOVA
From the Department of Cardiology, Balcali Hospital, Cukurova University, Adana, Turkey.
Abstract:   (4562 Views)
The purpose of this investigation was to assess the effect of captopril on both systemic (P.a) and pulmonary arterial pressures (PPA) in patients with high-altitude pulmonary hypertension (HAPH). Seventeen patients (mean age 44±6.8 years) with HAPH and mild to moderate systemic arterial hypertension were included in the study. All patients underwent right heart catheterization with measurements of systolic PPA (PPA,syst) , mean PPA, (P¯PA) and diastolic PPA (PPA,diast)• After 4 weeks placebo phase patients with a PPA, sst> 25 mmHg, P¯PA > 15 mm Hg and systemic diastolic blood pressure (Pa,diast) >100 mmHg were given captopril (50-75 mg at 8 am) for a period of 12 weeks. The statistical evaluation of the results was made using Student's t-test. It was found that captopril significantly decreases PPA and Pa.
Keywords: Captopril, pulmonary hypertension, systemic hypertension, high-altitude pulmonary hypertension.
Full-Text [PDF 342 kb]   (1789 Downloads)    
Type of Study: Original Research | Subject: Cardiovascular Surgery
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.